Cannell & Co. Biogen Inc. Transaction History

Cannell & Co.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $242,875 - $365,587	-1,028 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$258.66 - $342.55 $38,799 - $51,382	-150 Reduced 12.73%	1,028 $275,000
Q1 2020 May 05, 2020	BUY	$268.85 - $341.04 $15,593 - $19,780	58 Added 5.18%	1,178 $373,000
Q4 2019 Feb 10, 2020	BUY	$220.06 - $304.07 $246,467 - $340,558	1,120 New	1,120 $332,000

998

130M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

Stay updated on Cannell & Co. with notifications on news.